| Bone sarcoma | Soft tissue sarcoma |
---|
Age at 1st | Radiotherapy | No radiotherapy | Radiotherapy | No radiotherapy |
---|
Cancer diagnosis | Obs | SIR | Obs | SIR | Obs | SIR | Obs | SIR |
---|
20-39 yrs | 13 | 4.40* | 10 | 1.31 | 52 | 5.32* | 58 | 2.25* |
40-59 yrs | 42 | 3.71* | 40 | 1.23 | 129 | 2.41* | 219 | 1.37* |
60-79 yrs | 40 | 2.60* | 57 | 1.31 | 177 | 1.83* | 302 | 1.15* |
- *p < 0.05. Obs-observed number of subsequent primary sarcomas. SIR-standardized incidence ratio. Analysis includes adulthood (age 20–79 years at diagnosis) 1+ year survivors of any 1st cancer (excluding bone sarcoma or soft tissue sarcoma, respectively). Follow-up for second primary bone or soft tissue sarcoma continued to age 85 years. Patients with unknown radiotherapy were excluded.